CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 4 Open-market sale SVP, Head of Global Commercial sold 1,544 shares at $40.15 ($61,992)
- 4 Grant or award Global Head of R&D acquired 50,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 8,800 shares at an average $42.46 ($373,659)
- 4 Open-market sale Chief Executive Officer sold 8,800 shares at an average $41.87 ($368,472)
- 4 Grant or award Senior VP & General Counsel acquired 42,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Tech. Operations Officer gave up 642 shares (to pay taxes)
- 4/A Open-market sale Chief Executive Officer sold 200 shares at $38.40 ($7,680)
- 4 Open-market sale EVP & Chief R & QA Officer sold 22,400 shares at $40.07 ($897,568)
- 4 Open-market sale EVP & Chief R & QA Officer sold 100,203 shares at an average $37.87 ($3,795,062)
- 4 Open-market sale Chief Executive Officer sold 8,800 shares at an average $38.59 ($339,549)
- 4 Open-market sale EVP, R&D & Chief Scientific Of sold 18,327 shares at an average $39.79 ($729,265)
- 4 Open-market sale EVP & Chief Financial Officer sold 6,000 shares at an average $40.41 ($242,460)
- 4 Open-market sale Chief Executive Officer sold 8,800 shares at an average $42.13 ($370,748)
- 4 Open-market sale Chief Executive Officer sold 1,000 shares at an average $46.31 ($46,314)
- 4 Open-market sale Chief Executive Officer sold 17,800 shares at an average $44.65 ($794,733)
- 4 Open-market sale Director sold 1,183 shares at $46.50 ($55,010)
- 4 Exercise or conversion Director acquired 1,603 shares (option exercise)
- 4 Exercise or conversion EVP, R&D & Chief Scientific Of acquired 553 shares (option exercise)
Page 18 of 33 · 645 filings